5-Aminolevulinic Acid False-Positive Rates in Newly Diagnosed and Recurrent Glioblastoma: Do Pseudoprogression and Radionecrosis Play a Role? A Meta-Analysis
BackgroundSeveral studies have confirmed the impact of 5-aminolevulinic acid (5-ALA) on the extent of resection in newly diagnosed glioblastoma (GBM). However, there are controversies on the 5-ALA fluorescence status in recurrent GBM surgery, with specific reference to pseudoprogression or radionecr...
Váldodahkkit: | , , , , , , , , , , |
---|---|
Materiálatiipa: | Artihkal |
Giella: | English |
Almmustuhtton: |
Frontiers Media S.A.
2022-02-01
|
Ráidu: | Frontiers in Oncology |
Fáttát: | |
Liŋkkat: | https://www.frontiersin.org/articles/10.3389/fonc.2022.848036/full |